AnalystsMatt Miksic
Matt Miksic's Stock Forecasts

Analyst Ranking
Top 27%
#963 out of 3582 analysts
Average Return
+3.13%
Win Rate
53%24 out of 45
Risk vs Reward
Poor
Good

Matt Miksic's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
K2M Group Holdings IncKTWO
+51.92%$18.01$27.36
2017-10-09 -
2018-10-10
Strong Buy
Edwards Lifesciences CorpEW
+45.80%$79.38$115.74
2020-10-21 -
2021-10-21
Buy
Stryker CorpSYK
+31.71%$202.01$266.07
2020-10-29 -
2021-10-29
Buy
Edwards Lifesciences CorpEW
+30.82%$74.49$97.45
2020-04-23 -
2021-04-23
Buy
Abbott LaboratoriesABT
+29.52%$96.01$124.35
2020-04-16 -
2021-04-16
Buy

Matt Miksic's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
SmileDirectClub IncSDC
1Buy$4.00+101.01%Maintains
18 days ago
Edwards Lifesciences CorpEW
6Buy$140.00+26.58%Maintains
18 days ago
Vicarious Surgical IncRBOT
1Buy$16.00+191.97%Initiates Coverage On
18 days ago
Henry Schein IncHSIC
1BuyN/AN/AUpgrades
18 days ago
Medtronic plcMDT
4Buy$142.00+36.26%Maintains
a month ago
Alcon IncALC
4Buy$93.00+22.35%Maintains
2 months ago
Integra Lifesciences Holdings CorpIART
5Buy$87.00+29.39%Maintains
3 months ago
Organogenesis Holdings IncORGO
1Buy$25.00+232.01%Maintains
5 months ago
Globus Medical IncGMED
2Buy$91.00+32.54%Maintains
6 months ago
Boston Scientific CorpBSX
1Buy$52.00+21.89%Maintains
6 months ago
Abbott LaboratoriesABT
7Buy$130.00+4.99%Maintains
6 months ago
Baxter International IncBAX
3Buy$95.00+10.52%Maintains
a year ago
Stryker CorpSYK
2Buy$273.00+8.37%Maintains
a year ago
Johnson & JohnsonJNJ
4Buy$193.00+18.43%Maintains
a year ago
Sotera Health CoSHC
1BuyN/AN/AInitiates Coverage On
a year ago
Nuvasive IncNUVA
1Buy$87.00N/AMaintains
2 years ago
K2M Group Holdings IncKTWO
1Strong Buy$24.00N/AMaintains
4 years ago
Spectranetics CorpSPNC
1HoldN/AN/ADowngrades
5 years ago
Mimedx Group IncMDXG
1Strong Sell$9.00N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.